TrialNature communications2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Sue Ann Costa Clemens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.